- Home
- GH vs UAA Comparison
GH vs UAA Comparison
Compare GH & UAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GH
- UAA
- Stock Information
- Founded
- GH 2011
- UAA 1996
- Country
- GH United States
- UAA United States
- Employees
- GH N/A
- UAA N/A
- Industry
- GH Medical Specialities
- UAA Apparel
- Sector
- GH Health Care
- UAA Consumer Discretionary
- Exchange
- GH Nasdaq
- UAA Nasdaq
- Market Cap
- GH 4.7B
- UAA 3.7B
- IPO Year
- GH 2018
- UAA N/A
- Fundamental
- Price
- GH $45.13
- UAA $8.53
- Analyst Decision
- GH Strong Buy
- UAA Hold
- Analyst Count
- GH 14
- UAA 21
- Target Price
- GH $39.93
- UAA $9.19
- AVG Volume (30 Days)
- GH 1.9M
- UAA 7.7M
- Earning Date
- GH 02-20-2025
- UAA 02-06-2025
- Dividend Yield
- GH N/A
- UAA N/A
- EPS Growth
- GH N/A
- UAA N/A
- EPS
- GH N/A
- UAA N/A
- Revenue
- GH $692,256,000.00
- UAA $5,400,928,000.00
- Revenue This Year
- GH $32.21
- UAA N/A
- Revenue Next Year
- GH $16.90
- UAA $1.45
- P/E Ratio
- GH N/A
- UAA N/A
- Revenue Growth
- GH 29.20
- UAA N/A
- 52 Week Low
- GH $15.81
- UAA $6.17
- 52 Week High
- GH $45.66
- UAA $11.89
- Technical
- Relative Strength Index (RSI)
- GH 79.68
- UAA 49.77
- Support Level
- GH $36.45
- UAA $7.71
- Resistance Level
- GH $39.29
- UAA $8.54
- Average True Range (ATR)
- GH 2.35
- UAA 0.33
- MACD
- GH 0.75
- UAA 0.05
- Stochastic Oscillator
- GH 96.63
- UAA 81.19
About GH Guardant Health Inc.
Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2022, the company launched a lab-developed test version of Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
About UAA Under Armour Inc.
Under Armour develops, markets, and distributes athletic apparel, footwear, and accessories in North America, Asia-Pacific, Europe, and elsewhere. Consumers of its performance-based clothing and shoes include professional and amateur athletes, sponsored college and professional teams, and people with active lifestyles. The company sells merchandise through direct-to-consumer, including e-commerce and more than 400 combined factory house and brand house stores, and wholesale channels. Under Armour also operates a digital fitness app called MapMyFitness. The Baltimore-based company was founded in 1996 and is led by controlling shareholder Kevin Plank.